loading

Finanzdaten der Aprea Therapeutics Inc-Aktie (APRE)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
98.44%
0.00185
0.1181 0.1625 0.2058 0.3546
Operating Expenses
11.03%
3.1192
3.5059 4.248 3.4319 4.4516
Benefits Costs and Expenses
11.40%
2.9743
3.357 4.0951 3.1006 4.1384
Costs And Expenses
11.03%
3.1192
3.5059 4.248 3.4319 4.4516
Operating Income/Loss
7.98%
-3.1174
-3.3878 -4.0856 -3.226 -4.097
Income/Loss From Continuing Operations Before Tax
8.23%
-2.9724
-3.2389 -3.9327 -2.8948 -3.7838
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
8.23%
-2.9724
-3.2389 -3.9327 -2.8948 -3.7838
Net Income/Loss
8.23%
-2.9724
-3.2389 -3.9327 -2.8948 -3.7838
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4.76%
6.3729
6.0833 5.9939 0.1493 5.9398
Diluted Average Shares
4.76%
6.3729
6.0833 5.9939 0.1493 5.9398
Basic Earnings Per Share
11.32%
-0.47
-0.53 -0.66 -0.47 -0.64
Diluted Earnings Per Share
11.32%
-0.47
-0.53 -0.66 -0.57 -0.64
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.76
price down icon 0.11%
$99.42
price up icon 1.41%
$51.57
price down icon 1.29%
$88.25
price down icon 1.94%
$143.57
price up icon 0.64%
biotechnology ONC
$282.55
price up icon 0.04%
Kapitalisierung:     |  Volumen (24h):